[AFFX] Affymetrix, Inc.

Overview

Type of security: Stock

Sector: Capital Goods

Industry: Biotechnology: Laboratory Analytical Instruments

Market Capitalization: 1.13 B

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 14.01 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart AFFX

Refresh chart

Description: Affymetrix, Inc. provides life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein, and cell level primarily in the United States, Europe, Latin America, and Asia. The company operates in two segments, Affymetrix Core and eBioscience. The Affymetrix Core segment is engaged in the development, manufacture, and commercialization of systems for genetic analysis in the life sciences and diagnostic industry. This segment develops and markets GeneChip gene expression products and services; genotyping product line, such as the Axiom product line; arrays and assays with clinical research applications, such as the CytoScan and OncoScan products; QuantiGene line of singleplex and multiplex assays to serve customers in the research and translational medicine markets; and GeneTitan family of products consisting of the GeneTitan instrument system that runs genotyping and gene expression array plates. It also offers life science reagents, such as ExoSAP-I

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding80.77 M EPS0.2 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 3.85% Sales Growth - Q/Q-5.15% P/E69.95
P/E To EPS Growth P/S3.19 P/BV3.75 Price/Cash Per Share
Price/Free Cash Flow31.75 ROA2.19% ROE3.66% ROI2.48%
Current Ratio3.92 Quick Ratio3.01 Long Term Debt/Equity0.75 Debt Ratio0.19
Gross Margin60.36% Operating Margin5.12% Net Profit Margin3.11% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities49.42 M Cash From Investing Activities-20.43 M Cash From Operating Activities11.14 M Gross Profit57.08 M
Net Profit7.01 M Operating Profit8.53 M Total Assets538.37 M Total Current Assets239.19 M
Total Current Liabilities58.01 M Total Debt125.95 M Total Liabilities202.91 M Total Revenue88.97 M
Technical Data
High 52 week15.99 Low 52 week9.21 Last close14.01 Last change0%
RSI49.91 Average true range1.49 Beta Volume
Simple moving average 20 days-1.69% Simple moving average 50 days-0.62% Simple moving average 200 days
Performance Data
Performance Week-0.64% Performance Month0% Performance Quart1.33% Performance Half-3.8%
Performance Year18.75% Performance Year-to-date0% Volatility daily4.04% Volatility weekly9.04%
Volatility monthly18.52% Volatility yearly64.15% Relative Volume0% Average Volume3.43 M
New High New Low

News

2016-04-28 10:42:00 | Thermo Fisher Demonstrates Impressive Quarter

2016-04-28 06:02:00 | Thermo Fisher posts higher profit, revenue; raises forecast

2016-04-27 07:07:58 | U.S. companies skeptical of corporate China's advances

2016-04-07 14:05:52 | Inside Thermo Fisher’s Affymetrix Acquisition: A Growth Gauge

2016-04-04 11:10:03 | Thermo Fisher Steals Affymetrix Deal, Expands Antibody Line

2016-03-31 17:09:50 | AFFYMETRIX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive A

2016-03-31 16:28:00 | Thermo Fisher TMO Completes Affymetrix Deal, Jim Cramer: 'Happy to Move Past The Noise'

2016-03-31 13:40:21 | Thermo Fisher Scientific Completes Acquisition of Affymetrix Following Approval of Transaction by Affymetrix Stockholders

2016-03-31 13:23:00 | Thermo Fisher Scientific Completes Acquisition of Affymetrix Following Approval of Transaction by Affymetrix Stockholders

2016-03-30 18:24:00 | WebMD Health Set to Join the S&P MidCap 400; SciClone Pharmaceuticals to Join S&P SmallCap 600

2016-03-30 12:28:00 | Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Affymetrix, Inc.

2016-03-29 14:40:06 | Thermo Fisher to Acquire Affymetrix, Origin's Bid Falls Flat

2016-03-29 09:55:00 | Affymetrix AFFX Stock Retreats After Origin Withdraws Takeover Bid

2016-03-29 08:18:14 | Affymetrix, Inc. breached its 50 day moving average in a Bearish Manner : AFFX-US : March 29, 2016

2016-03-28 19:51:17 | Affymetrix recommends against Origin deal, citing China concerns

2016-03-28 18:32:39 | Origin withdraws offer to buy Affymetrix

2016-03-28 15:47:48 | Affymetrix backs Thermo Fisher deal, says rival bid not superior

2016-03-28 15:30:07 | Thermo Fisher Scientific Agrees with Affymetrix that Merger Agreement Remains Superior

2016-03-28 14:58:00 | Affymetrix AFFX Stock Drops After Rejecting Origin Technologies Takeover Bid

2016-03-28 14:32:58 | Affymetrix backs Thermo Fisher deal

2016-03-28 14:16:00 | Affymetrix Board of Directors Reaffirms Support of Merger with Thermo Fisher

2016-03-24 12:14:00 | Affymetrix AFFX Stock Lower, to Engage in Bid Talks with Origin Technologies

2016-03-23 21:58:00 | Affymetrix to Engage in Discussions With Origin Technologies

2016-03-23 16:40:07 | Affymetrix Shareholders To Choose Between Origin, Thermo Fisher

2016-03-23 14:17:14 | Office Depot ODP, Valeant VRX Among 5 of the Day’s Big Winners

2016-03-23 10:27:27 | Thermo Fisher Scientific Remains Confident That Origin Technologies’ Proposal is Not Likely to Result in a Superior Proposal

2016-03-23 09:43:18 | Affymetrix says raised Origin offer could lead to superior proposal

2016-03-22 17:20:32 | Origin Technologies raises offer for Affymetrix to $17/shr

2016-03-22 12:20:14 | Thermo Fisher, Origin Tech vie for Affymetrix shareholder votes

2016-03-22 09:33:28 | Thermo Fisher Scientific Issues Open Letter to Affymetrix Stockholders

2016-03-20 20:42:51 | Affymetrix rejects rival bid, supports Thermo Fisher merger

2016-03-20 19:13:37 | Thermo Fisher Scientific Issues Open Letter to Affymetrix Stockholders

2016-03-18 12:22:40 | Former Affymetrix executives offer to buy company; challenge ThermoFisher

2016-03-08 06:30:00 | Affymetrix Receives Grant for Non-Invasive Genomic Profiling of Bladder Cancer

2016-01-16 10:20:03 | 4 Top BioPharma Movers of the Past Week

2016-01-12 06:50:04 | Bio-Genesys and Affymetrix Partner to Offer Animal Genomic Testing Services to Professional Farming Operations

2016-01-11 12:47:18 | Keep an Eye on These 4 High-Flying Stocks Today

2016-01-08 18:06:11 | Thermo Fisher Scientific to Acquire Affymetrix

2016-01-08 17:56:10 | Thermo Fisher Scientific to Acquire Affymetrix

2016-01-07 06:41:56 | Affymetrix Expands Agrigenomics Genotyping Portfolio with New Targeted Sequencing Solution and Array Formats

2015-12-02 06:44:42 | Affymetrix and Reveal Biosciences Partner to Offer RNA ISH Tissue Staining, Imaging, and Image Analysis Services